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Objective: Low birthweight is associated with a decreased risk of childhood leuke-
mia and an increased risk of both cardiovascular disease and all-cause mortality in
adult life. Possible biological mediators include systemic innate immunity and
inﬂammation. We tested the hypothesis that birthweight was inversely associated
with serum high sensitivity C reactive protein assay (hsCRP), a measure of both
innate immunity and systemic inﬂammation.
Methods: Data on birthweight and current anthropometric measures along with a
range of exposures were collected at 1 and 3 years of age in a population-based
cohort study of young children living in Havana, Cuba. A total of 986 children aged
3-years-old provided blood samples that were analyzed for serum hsCRP levels.
Results: Nearly 49% of children had detectable hsCRP levels in their serum. Lower
birthweight was linearly associated with the natural log of hsCRP levels (beta coeﬃ-
cient 20.70 mg L21 per kg increase in birthweight, 95% CI: 21.34 to 20.06). This
was attenuated but still present after adjustment for the child’s sex and municipality
(20.65 mg L21 per kg birthweight; 95% CI: 21.38 to10.08). There were no associ-
ations between growth from birth or anthropometric measures at 3 years and
systemic inﬂammation.
Conclusions: Birthweight was inversely associated with serum hsCRP levels in chil-
dren aged 3 years living in Cuba. These observations provide a potential mechanism
that is present at the age of 3 years to explain the association between low birthweight
and both decreased childhood leukemia and increased cardiovascular disease in adults.
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1 | INTRODUCTION
Exposures from conception onwards are well recognized to
impact birthweight and subsequent diseases in adulthood
(Gluckman et al., 2008). The associations between lower
birthweight and decreased risk of childhood leukemia (Bel-
son et al., 2007; Hjalgrim et al., 2004; Paltiel et al., 2004)
and increased cardiovascular disease (Huxley et al., 2007;
Mu et al., 2012; Risnes et al., 2011) and all-cause mortality
(Risnes et al., 2011) in adults are well recognized although
the pathogenetic mechanisms are unclear. Potential biological
processes that may be on the casual pathway for these obser-
vations include innate immunity whereby immune surveil-
lance prevents the development of aberrant cells into clinical
malignancies (Bindea et al., 2010; Chow et al., 2011;
Ostrand-Rosenberg, 2008), and systemic inﬂammation,
which is known to be a risk factor for cardiovascular disease
(Danesh et al., 2000; Ridker and Cook, 2004; Ridker et al.,
1998, 2000). High sensitivity C reactive protein (hsCRP) is a
member of the pentraxin protein family, and is a biomarker
that contributes to both innate immunity (Du Clos and Mold,
2004; Simons et al., 2014) and also systemic inﬂammation
(Black et al., 2004; Mortensen, 2001), and is positively asso-
ciated with higher all-cause mortality in adults (Zacho et al.,
2010). Prospective studies in children may increase under-
standing of these associations by determining if birth-
weight is associated with increased hsCRP levels in later
childhood.
Cuba has an excellent health care system that delivers
infant mortality rates comparable to much richer countries
(Cooper et al., 2006), with good health infrastructure provid-
ing a unique environment where risk factors for disease can
be studied. We have used data from a prospective study in
young children to test the primary hypothesis that low birth
weight is associated with increased hsCRP levels at the age
of 3 years.
2 | MATERIALS AND METHODS
2.1 | Study population and setting
The study design is a prospective observational epidemiolog-
ical study. All children aged between 12 and 15 months who
were living in Havana, Cuba, between March 2010 and
March 2011 and who attended one of 17 policlinics, nested
in four municipalities in Havana, Cuba, were eligible to be
randomly selected to participate in the study (Arroyo Nar-
anjo, Cerro, Habana del Este, La Lisa). Recruitment for the
study (Appendix) has been described in detail elsewhere
(Venero-Fernandez et al., 2013). The study protocol was
approved by the local Havana Scientiﬁc Committee in Cuba
and also by the University of Nottingham Medical School
Ethics Committee in the United Kingdom.
2.2 | Data collection
The study was initially designed to identify environmental
exposures that may increase the risk of asthma or allergic
disease in Cuba (Fundora Hernandez et al., 2014; Suarez-
Medina et al., 2014; Venero-Fernandez et al., 2013). The
baseline data collection in eligible children at the age of 1
year consisted of an interviewer-administered questionnaire
that collated the responses from the parent/caregiver about
prenatal and postnatal exposures of the child, their living
environment, and the medical history of the family. Birth-
weight was obtained from the child’s medical records of the
readings taken at the place of birth. Speciﬁc questions
focused on smoking history, including that of the mother
during pregnancy, and also information on exposure to indi-
viduals who smoke tobacco in the infant’s home. The chil-
dren and their caregivers were resurveyed 2 years later when
the children were 3-years-old and clinically stable. Data on
the height and weight at the time of the interview were also
collected using the measuring equipment and weighting
scales available in the policlinic which were calibrated every
6 months by the Ministry of Health. For those 3-year-old
children whose parents gave consent, a blood sample was
taken. This was frozen and subsequently analyzed for serum
hsCRP using an immunoturbidimetric assay (SpinReact,
Spain) on a SpinLab 100 (SpinReact, Spain) analyzer in a
standardized manner designed to minimize measurement
error (Spinreact high sensitivity CRP assay).
2.3 | Data analysis
The data were entered into an electronic database, cleaned,
and checked for errors. All statistical analyses were carried
out in Stata v14 (StataCorp, Texas) using the survey com-
mands (svyset) to allow for the clustered survey design (Stata
Corp). The distribution of serum hsCRP levels was trans-
formed into natural logarithms after adding 10.00001 to
accommodate undetectable values.
Linear regression analyses were then performed using
logCRP at the age of 3 years as the primary endpoint and
birthweight as the main independent variable. The associa-
tions of weight at 3 years and change in weight since birth
with logCRP were secondary endpoints. A number of further
exposures were added to the model in a stepwise manner and
they were retained if they changed the size of statistically
signiﬁcant associations by 10% or more. These were munici-
pality, sex, duration of exclusive breastfeeding (categorical),
mother smoking in pregnancy, presence of smokers in the
household at 1 year and at 3 years of age (categorical), self-
reported pollution in their locality at age 1 year and at 3
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Mean age in years (range) 3 (3–3) 3 (3–3) 3 (3–3)
Skin color (%) White 695 (45) 256 (46) 439 (45)
Mixed 652 (42) 238 (43) 414 (42)
Black 196 (13) 63 (11) 133 (13)
Gender (%) Female 753 (49) 278 (50) 475 (48)
Male 790 (51) 279 (50) 511 (52)
Municipality (%) Habana Este 480 (31) 135 (24) 345 (35)
Cerro 229 (15) 88 (16) 141 (14)
La Lisa 264 (17) 204 (37) 60 (6)
Arroyo
Naranjo
570 (37) 130 (23) 440 (45)
Median number of siblings (IQR) – 1 (0–2) 1 (0–1) 1 (0–2)
Median duration of breastfeeding, months, (IQR) 4 (2–5) 4 (2–5) 4 (2–5)
Mean age of mother at birth in years (sd) – 26.7 (6.2) 26.2 (6.2) 26.9 (6.2)
N5 1542 N5 985
Mothers education Primary 26 (2) 11 (2) 15 (2)
Secondary 417 (27) 162 (29) 255 (26)
Pre-University 895 (58) 305 (55) 590 (60)
University 205 (13) 79 (14) 126 (13)
Smokers living in home at 1 year No 726 (47) 258 (46) 468 (47)
Yes 817 (53) 299 (54) 518 (53)
Smokers living in home at 3 years No 742 (48) 267 (48) 475 (48)
Yes 801 (52) 290 (52) 511 (52)
Self-reported pollution at home at 1 year Yes 1126 (73) 423 (76) 703 (71)
No 417 (27) 134 (24) 283 (29)
Self-reported pollution at home in 3 years Yes 1058 (69) 376 (68) 682 (69)
No 485 (31) 181 (32) 304 (31)
Birthweight, kg (sd) – 3.32 (0.52) 3.31 (0.52) 3.33 (0.52)
N5 1540 N5 556 N5 984
Weight at 3 years, kg (sd) – 15.83 (2.58) 15.66 (2.62) 15.93 (2.55)
Height at year 3, m (sd) – 0.96 (0.07) 0.95 (0.07) 0.96 (0.07)
IQR5 interquartile range.
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years of age, mother’s age (categorical), number of siblings
(categorical) and maternal education (categorical). Interac-
tions were explored for sex using the likelihood ratio testing
with a P value of <0.10 as evidence of an interaction. To
explore the possibility of subclinical infections driving
higher levels of serum hsCRP, sensitivity analyses were
implemented restricting the study population to those with
an hsCRP level of less than either 10 or 20 mg L21.
Assumptions of linearity were tested by comparing the linear
model with the categorical model using likelihood ratio tests.
3 | RESULTS
Of the 3-year-old 1,543 children who participated in the sur-
vey, 986 (64%) provided blood samples for analysis of
serum CRP levels. Children who provided blood were simi-
lar to those who did not in terms of birthweight, but were
slightly more likely to live in the Habana del Este and
Arroyo Naranjo municipalities than those who did not con-
tribute blood samples (Table 1). Forty-nine percent of chil-
dren who provided blood samples had a detectable serum
CRP level and the distribution is presented in Figure 1, with
a lowest detectable value of 0.01 mg L21. The association
with birthweight presented in Figure 2.
In the primary analysis of the association between birth-
weight and log serum hsCRP levels at age 3 years (Table 2),
there was a signiﬁcant linear association in the univariate
analysis (20.70 mg L21 kg21 birthweight, 95% conﬁdence
intervals CI: 21.34 to 20.06). There was no eﬀect modiﬁca-
tion of this association by sex. These associations persisted
in sensitivity analyses restricting the population to those with
serum hsCRP measurements <20 mg L21 (20.65
mg L21 kg21; 95% CI: 21.37 to 10.78) and< 10 mg L21
(20.59 mg L21 kg21; 95%CI: 21.31 to 10.14).
Both place of location (municipality) and the child’s sex
were signiﬁcant confounding factors (Table 2). Adding both
of these variables to the model gave a similar association as
seen in the univariate model (20.65 mg L21 kg21; 95% CI:
21.38 to 10.08, P5 0.07). Repeating the univariate analysis
with no adjustment for sampling gave a similar qualitative
association with wider conﬁdence intervals between the
highest category of serum hsCRP levels and birthweight
(20.70 mg L21 kg21, 95%CI: 21.56 to 10.16).
There were no signiﬁcant associations between CRP lev-
els at the age of 3 years and either weight at 3 years, body
mass index at 3 years, height at 3 years or change in weight
at 3 years from birth. Similarly, there was no association
with either the presence of smokers in the house at age 3
years or the duration of exclusive breastfeeding with logCRP
levels.
4 | DISCUSSION
To our knowledge this is the largest prospective population-
based study to investigate the association between birth-
weight and serum hsCRP levels in 3-year-old children. Our
data demonstrate that birthweight is inversely associated
with serum hsCRP measurements at 3 years, with a one kg
increase in weight associated with an 50% decrease in
serum hsCRP. These associations have potential implications
for understanding how low birthweight is associated with
disease in later life.
The strengths of our data include the randomly selected
prospective population-based study from which these chil-
dren were recruited and the detailed phenotypic information
collected on a number of environmental exposures from
pregnancy onwards, allowing consideration of potential con-
founding or causal exposures. The data on birthweight were
collected from medical records obtained as part of the
infant’s postnatal care, giving conﬁdence that these data are
not inﬂuenced by recall bias. Subsequent data on weight and
height at the age of 3 years were also collected at the poli-
clinic using validated medical equipment. The blood samples
FIGURE 1 Distribution of serum hsCRP levels in study
population
FIGURE 2 Scatter graph of the association between serum
high sensitivity CRP levels and birthweight
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were collected, processed and stored in a standardized man-
ner and then analyzed in batches in a central laboratory, pro-
viding conﬁdence in the integrity of these data. The
persistence of the associations after sensitivity analyses
restricted to lower levels of serum hsCRP suggests that these
observations are robust.
Although we were only able to collect blood samples for
analysis from 64% of those who attended, signiﬁcant selec-
tion bias is unlikely as those who did provide blood were
generally similar to those who did not. The blood samples
were collected in the early morning through the year in a
tropical country and hence temperature and ambient pollu-
tion may be expected to vary according to season and
weather conditions. We are unable to adjust for these factors,
but anticipate that they are most likely to generate a non-
systemic measurement error in CRP values that would not
bias our observations. Similarly, although we only recruited
individuals with no current symptoms of infection, we were
unable to exclude infection at the time of blood collection;
again this would be expected to lead to non-systemic mea-
surement error, and hence would be unlikely to bias our
observations unless low birthweight increased susceptibility
to infection and hence prevalence of subclinical infection.
There are no existing population-based studies of the
association between birthweight and serum hsCRP levels in
young children that we are aware of. One study from the UK
in 553 children aged 10–11 years reported a median hsCRP
value of 0.15 mg L21 and no association with birthweight
either before or after adjustment for current body size (Cook
et al., 2000). An analysis of 996 Mexican American children
aged 6–11 years who provided data for the Third National
Health and Nutrition Survey in 1988–1994 in the USA
reported that 11% of children had CRP values of 2.1 mg L21
or more, and that again there was no association with birth-
weight in this population (Gillum, 2003). One limitation of
the second study is the unavailability of the high sensitivity
CRP assay that precludes direct comparison with our study
population. However, the aforementioned two studies in chil-
dren aged 6–11 years did report a positive association
between body habitus and serum CRP, which was not present
in our larger dataset. It is possible that the mechanism that
drives the well recognized association between adiposity and
serum hsCRP (Fogarty et al., 2008) is not established at the
age of 3 years.
Other studies of the association between birthweight and
CRP levels have been in adults and these studies are prob-
ably more susceptible to confounding by environmental fac-
tors as the participants will have had more time to
accumulate exposures. In particular, it is unclear if current
body fat is on the causal pathway or may be considered a
confounding factor. The potential importance of confounding
by adiposity is reﬂected in the fact that the majority of stud-
ies of the association between birthweight and CRP in adults
only observed an association after adjustment for body habi-
tus. The MIDSPAN family study reported no initial associa-
tion between serum hsCRP and birth weight in preliminary
analyses in 1663 individuals aged 30–59 years, but after
adjustment for body mass index an inverse linear association
between serum hsCRP and birth weight was observed, with
a 10.7% decrease in hsCRP for each 1kg increase in birth
weight (Sattar et al., 2004). Data from the Bogalusa Heart
Study similarly reported an inverse linear association
between hsCRP in 776 adults aged 24–43 years after adjust-
ing for the confounding factors that included BMI (Bhuiyan
et al., 2011). Data from 1461 participants from a birth cohort
in the Philippines who were aged 21 years found no initial
association between birthweight and serum CRP in tertiles in
initial analyses, but a negative association was observed after
adjustment for a number of confounding factors including
current waist circumference and skinfold thickness (McDade
et al., 2010). Data from a birth cohort from Finland of 5840
participants aged 31 years, observed that hsCRP levels were
16% higher for each 1 kg decrease in birth weight after
adjustment for body mass index, and 6% higher without
adjustment for BMI (Tzoulaki et al., 2008). Analysis of data
from the US National Longitudinal Study of Adolescent
Health reported that, at the age of 24–32 years, the associa-
tion between birth weight and serum hsCRP was non-linear,
being positive for birth weights <2.8 kg and above this
threshold the association was negative (McDade et al.,
2014).
The observation that low birthweight is associated with
higher levels of cardiovascular disease (Huxley et al., 2007;
Mu et al., 2012; Risnes et al., 2011) and all-cause mortality
in adults is well recognized. The association of higher birth-
weight with childhood leukemia also has been the topic of a
number of studies (Belson et al., 2007; Hjalgrim et al., 2004;
Paltiel et al., 2004). Our observations that low birthweight is
associated with higher circulating hsCRP levels at the age of
3 years do not demonstrate that this is the biological mecha-
nism that explains these observations. However, it does per-
mit us to speculate that via its role in contributing to innate
immunity (Du Clos and Mold, 2004; Simons et al., 2014),
inﬂammation may play a role in the subsequent susceptibility
to the development of diseases seen in individuals with low
birthweight (Black et al., 2004; Mortensen, 2001). There is
no clear direction of causality as children with low birth
weight have more respiratory infections compared to a con-
trol population (Chan et al, 1989), while it is recognized that
CRP boosts the innate immune response to bacteria (Ng
et al., 2007), with particular activity against Streptococcus
pneumonia (Thomas-Rudolph et al., 2007). Further longitu-
dinal studies of the association between birthweight and dis-
eases will be required to clarify these issues, adjusting for
serum hsCRP levels in childhood.
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In summary, we have identiﬁed that in a population of
children aged 3 years, there is an inverse association between
birthweight and serum hsCRP levels. These data provide one
potential explanation for how low birthweight is associated
with changes in risk of disease and mortality in later life.
Further follow up of this cohort with the particular addition
of cardiovascular outcome measures will permit increased
understanding of the biological processes that drive these
conditions.
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Birthweight (kg) 20.70 (21.34 to 20.06) 20.78 (21.45 to 20.10) 20.58 (21.29 to 10.13) 20.65 (21.38 to 10.08)
Weight at 3 years (kg) 20.05 (20.22 to 10.13) 2
Change in weight
in ﬁrst 3 years (kg)
20.02 (20.22 to 10.19) 2
Beta-coeﬃcient5 natural log CRP (mg L21) per kg increase in birthweight.
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